- Home
- CALC vs SIDU Comparison
CALC vs SIDU Comparison
Compare CALC & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- SIDU
- Stock Information
- Founded
- CALC 2011
- SIDU 2012
- Country
- CALC United States
- SIDU United States
- Employees
- CALC N/A
- SIDU N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- SIDU Telecommunications Equipment
- Sector
- CALC Health Care
- SIDU Telecommunications
- Exchange
- CALC Nasdaq
- SIDU Nasdaq
- Market Cap
- CALC 32.4M
- SIDU 30.0M
- IPO Year
- CALC N/A
- SIDU 2021
- Fundamental
- Price
- CALC $3.80
- SIDU $2.02
- Analyst Decision
- CALC Strong Buy
- SIDU
- Analyst Count
- CALC 2
- SIDU 0
- Target Price
- CALC $14.50
- SIDU N/A
- AVG Volume (30 Days)
- CALC 133.2K
- SIDU 562.7K
- Earning Date
- CALC 08-11-2025
- SIDU 08-18-2025
- Dividend Yield
- CALC N/A
- SIDU N/A
- EPS Growth
- CALC N/A
- SIDU N/A
- EPS
- CALC N/A
- SIDU N/A
- Revenue
- CALC N/A
- SIDU $3,860,985.00
- Revenue This Year
- CALC N/A
- SIDU $144.49
- Revenue Next Year
- CALC N/A
- SIDU N/A
- P/E Ratio
- CALC N/A
- SIDU N/A
- Revenue Growth
- CALC N/A
- SIDU N/A
- 52 Week Low
- CALC $1.42
- SIDU $1.14
- 52 Week High
- CALC $5.97
- SIDU $7.65
- Technical
- Relative Strength Index (RSI)
- CALC 73.90
- SIDU 62.73
- Support Level
- CALC $3.37
- SIDU $1.88
- Resistance Level
- CALC $4.26
- SIDU $2.19
- Average True Range (ATR)
- CALC 0.41
- SIDU 0.13
- MACD
- CALC 0.21
- SIDU 0.01
- Stochastic Oscillator
- CALC 82.80
- SIDU 66.80
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.